<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1999-07-15" modified="2020-10-07" version="205">
<accession>O15516</accession>
<accession>A0AV01</accession>
<accession>A2I2N9</accession>
<accession>O14516</accession>
<accession>Q9UIT8</accession>
<name>CLOCK_HUMAN</name>
<protein>
<recommendedName>
<fullName>Circadian locomoter output cycles protein kaput</fullName>
<shortName>hCLOCK</shortName>
<ecNumber>2.3.1.48</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Class E basic helix-loop-helix protein 8</fullName>
<shortName>bHLHe8</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">CLOCK</name>
<name type="synonym">BHLHE8</name>
<name type="synonym">KIAA0334</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="Genomics" volume="57" first="189" last="200">
<title>Molecular cloning and characterization of the human CLOCK gene: expression in the suprachiasmatic nuclei.</title>
<authorList>
<person name="Steeves T.D.L."/>
<person name="King D.P."/>
<person name="Zhao Y."/>
<person name="Sangoram A.M."/>
<person name="Du F."/>
<person name="Bowcock A.M."/>
<person name="Moore R.Y."/>
<person name="Takahashi J.S."/>
</authorList>
<dbReference type="PubMed" id="10198158"/>
<dbReference type="DOI" id="10.1006/geno.1998.5675"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="2">
<citation type="submission" date="2006-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NHLBI resequencing and genotyping service (RS&amp;G)"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="DNA Res." volume="4" first="141" last="150">
<title>Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.</title>
<authorList>
<person name="Nagase T."/>
<person name="Ishikawa K."/>
<person name="Nakajima D."/>
<person name="Ohira M."/>
<person name="Seki N."/>
<person name="Miyajima N."/>
<person name="Tanaka A."/>
<person name="Kotani H."/>
<person name="Nomura N."/>
<person name="Ohara O."/>
</authorList>
<dbReference type="PubMed" id="9205841"/>
<dbReference type="DOI" id="10.1093/dnares/4.2.141"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="1997-08" db="EMBL/GenBank/DDBJ databases">
<title>Molecular cloning of human Clock cDNA 5'-end.</title>
<authorList>
<person name="Ikeda M."/>
<person name="Takehara N."/>
<person name="Ebisawa T."/>
<person name="Yamauchi T."/>
<person name="Nomura M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-349</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="Science" volume="293" first="510" last="514">
<title>Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors.</title>
<authorList>
<person name="Rutter J."/>
<person name="Reick M."/>
<person name="Wu L.C."/>
<person name="McKnight S.L."/>
</authorList>
<dbReference type="PubMed" id="11441146"/>
<dbReference type="DOI" id="10.1126/science.1060698"/>
</citation>
<scope>DNA-BINDING</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="7091" last="7097">
<title>Histone acetyltransferase-dependent chromatin remodeling and the vascular clock.</title>
<authorList>
<person name="Curtis A.M."/>
<person name="Seo S.B."/>
<person name="Westgate E.J."/>
<person name="Rudic R.D."/>
<person name="Smyth E.M."/>
<person name="Chakravarti D."/>
<person name="FitzGerald G.A."/>
<person name="McNamara P."/>
</authorList>
<dbReference type="PubMed" id="14645221"/>
<dbReference type="DOI" id="10.1074/jbc.m311973200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH KAT2B; CREBBP AND EP300</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="Nat. Genet." volume="38" first="312" last="319">
<title>Feedback repression is required for mammalian circadian clock function.</title>
<authorList>
<person name="Sato T.K."/>
<person name="Yamada R.G."/>
<person name="Ukai H."/>
<person name="Baggs J.E."/>
<person name="Miraglia L.J."/>
<person name="Kobayashi T.J."/>
<person name="Welsh D.K."/>
<person name="Kay S.A."/>
<person name="Ueda H.R."/>
<person name="Hogenesch J.B."/>
</authorList>
<dbReference type="PubMed" id="16474406"/>
<dbReference type="DOI" id="10.1038/ng1745"/>
</citation>
<scope>MUTAGENESIS OF GLU-116; GLY-332; HIS-360; GLU-367; VAL-601 AND PRO-840</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2008" name="Mol. Cell. Biochem." volume="317" first="169" last="177">
<title>CLOCK/BMAL1 regulates human nocturnin transcription through binding to the E-box of nocturnin promoter.</title>
<authorList>
<person name="Li R."/>
<person name="Yue J."/>
<person name="Zhang Y."/>
<person name="Zhou L."/>
<person name="Hao W."/>
<person name="Yuan J."/>
<person name="Qiang B."/>
<person name="Ding J.M."/>
<person name="Peng X."/>
<person name="Cao J.M."/>
</authorList>
<dbReference type="PubMed" id="18587630"/>
<dbReference type="DOI" id="10.1007/s11010-008-9846-x"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="38987" last="39000">
<title>The transcriptional repressor ID2 can interact with the canonical clock components CLOCK and BMAL1 and mediate inhibitory effects on mPer1 expression.</title>
<authorList>
<person name="Ward S.M."/>
<person name="Fernando S.J."/>
<person name="Hou T.Y."/>
<person name="Duffield G.E."/>
</authorList>
<dbReference type="PubMed" id="20861012"/>
<dbReference type="DOI" id="10.1074/jbc.m110.175182"/>
</citation>
<scope>INTERACTION WITH ID2</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="25891" last="25902">
<title>Biochemical analysis of the canonical model for the mammalian circadian clock.</title>
<authorList>
<person name="Ye R."/>
<person name="Selby C.P."/>
<person name="Ozturk N."/>
<person name="Annayev Y."/>
<person name="Sancar A."/>
</authorList>
<dbReference type="PubMed" id="21613214"/>
<dbReference type="DOI" id="10.1074/jbc.m111.254680"/>
</citation>
<scope>INTERACTION WITH ARNTL; CRY1 AND PER2</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E25612" last="E25612">
<title>Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man.</title>
<authorList>
<person name="Charmandari E."/>
<person name="Chrousos G.P."/>
<person name="Lambrou G.I."/>
<person name="Pavlaki A."/>
<person name="Koide H."/>
<person name="Ng S.S."/>
<person name="Kino T."/>
</authorList>
<dbReference type="PubMed" id="21980503"/>
<dbReference type="DOI" id="10.1371/journal.pone.0025612"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NR3C1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2011" name="Science" volume="332" first="1313" last="1317">
<title>A DNA damage response screen identifies RHINO, a 9-1-1 and TopBP1 interacting protein required for ATR signaling.</title>
<authorList>
<person name="Cotta-Ramusino C."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K."/>
<person name="Sowa M.E."/>
<person name="Harper J.W."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="21659603"/>
<dbReference type="DOI" id="10.1126/science.1203430"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2011" name="Science" volume="333" first="1881" last="1885">
<title>Histone lysine demethylase JARID1a activates CLOCK-BMAL1 and influences the circadian clock.</title>
<authorList>
<person name="DiTacchio L."/>
<person name="Le H.D."/>
<person name="Vollmers C."/>
<person name="Hatori M."/>
<person name="Witcher M."/>
<person name="Secombe J."/>
<person name="Panda S."/>
</authorList>
<dbReference type="PubMed" id="21960634"/>
<dbReference type="DOI" id="10.1126/science.1206022"/>
</citation>
<scope>INTERACTION WITH KDM5A</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2012" name="J. Thromb. Haemost." volume="10" first="662" last="669">
<title>Diurnal expression of the thrombopoietin gene is regulated by CLOCK.</title>
<authorList>
<person name="Tracey C.J."/>
<person name="Pan X."/>
<person name="Catterson J.H."/>
<person name="Harmar A.J."/>
<person name="Hussain M.M."/>
<person name="Hartley P.S."/>
</authorList>
<dbReference type="PubMed" id="22284746"/>
<dbReference type="DOI" id="10.1111/j.1538-7836.2012.04643.x"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2013" name="Am. J. Physiol." volume="304" first="R1053" last="R1064">
<title>Mechanism of the circadian clock in physiology.</title>
<authorList>
<person name="Richards J."/>
<person name="Gumz M.L."/>
</authorList>
<dbReference type="PubMed" id="23576606"/>
<dbReference type="DOI" id="10.1152/ajpregu.00066.2013"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2013" name="J. Biol. Chem." volume="288" first="36878" last="36889">
<title>Cyclin-dependent kinase 5 (Cdk5) regulates the function of CLOCK protein by direct phosphorylation.</title>
<authorList>
<person name="Kwak Y."/>
<person name="Jeong J."/>
<person name="Lee S."/>
<person name="Park Y.U."/>
<person name="Lee S.A."/>
<person name="Han D.H."/>
<person name="Kim J.H."/>
<person name="Ohshima T."/>
<person name="Mikoshiba K."/>
<person name="Suh Y.H."/>
<person name="Cho S."/>
<person name="Park S.K."/>
</authorList>
<dbReference type="PubMed" id="24235147"/>
<dbReference type="DOI" id="10.1074/jbc.m113.494856"/>
</citation>
<scope>PHOSPHORYLATION AT THR-451 AND THR-461</scope>
<scope>MUTAGENESIS OF THR-451 AND THR-461</scope>
<scope>INTERACTION WITH THE COMPLEX P35/CDK5</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2013" name="J. Neurosci." volume="33" first="10221" last="10234">
<title>p75 neurotrophin receptor is a clock gene that regulates oscillatory components of circadian and metabolic networks.</title>
<authorList>
<person name="Baeza-Raja B."/>
<person name="Eckel-Mahan K."/>
<person name="Zhang L."/>
<person name="Vagena E."/>
<person name="Tsigelny I.F."/>
<person name="Sassone-Corsi P."/>
<person name="Ptacek L.J."/>
<person name="Akassoglou K."/>
</authorList>
<dbReference type="PubMed" id="23785138"/>
<dbReference type="DOI" id="10.1523/jneurosci.2757-12.2013"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2013" name="Oncogene" volume="32" first="4883" last="4891">
<title>CLOCK is a substrate of SUMO and sumoylation of CLOCK upregulates the transcriptional activity of estrogen receptor-alpha.</title>
<authorList>
<person name="Li S."/>
<person name="Wang M."/>
<person name="Ao X."/>
<person name="Chang A.K."/>
<person name="Yang C."/>
<person name="Zhao F."/>
<person name="Bi H."/>
<person name="Liu Y."/>
<person name="Xiao L."/>
<person name="Wu H."/>
</authorList>
<dbReference type="PubMed" id="23160374"/>
<dbReference type="DOI" id="10.1038/onc.2012.518"/>
</citation>
<scope>SUMOYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH ESR1</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2013" name="Physiol. Rev." volume="93" first="107" last="135">
<title>Metabolism and the circadian clock converge.</title>
<authorList>
<person name="Eckel-Mahan K."/>
<person name="Sassone-Corsi P."/>
</authorList>
<dbReference type="PubMed" id="23303907"/>
<dbReference type="DOI" id="10.1152/physrev.00016.2012"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2014" name="J. Invest. Dermatol." volume="134" first="610" last="619">
<title>A meeting of two chronobiological systems: circadian proteins Period1 and BMAL1 modulate the human hair cycle clock.</title>
<authorList>
<person name="Al-Nuaimi Y."/>
<person name="Hardman J.A."/>
<person name="Biro T."/>
<person name="Haslam I.S."/>
<person name="Philpott M.P."/>
<person name="Toth B.I."/>
<person name="Farjo N."/>
<person name="Farjo B."/>
<person name="Baier G."/>
<person name="Watson R.E."/>
<person name="Grimaldi B."/>
<person name="Kloepper J.E."/>
<person name="Paus R."/>
</authorList>
<dbReference type="PubMed" id="24005054"/>
<dbReference type="DOI" id="10.1038/jid.2013.366"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2014" name="Trends Cell Biol." volume="24" first="90" last="99">
<title>Molecular architecture of the mammalian circadian clock.</title>
<authorList>
<person name="Partch C.L."/>
<person name="Green C.B."/>
<person name="Takahashi J.S."/>
</authorList>
<dbReference type="PubMed" id="23916625"/>
<dbReference type="DOI" id="10.1016/j.tcb.2013.07.002"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2015" name="Mol. Cell" volume="58" first="743" last="754">
<title>Cancer/testis antigen PASD1 silences the circadian clock.</title>
<authorList>
<person name="Michael A.K."/>
<person name="Harvey S.L."/>
<person name="Sammons P.J."/>
<person name="Anderson A.P."/>
<person name="Kopalle H.M."/>
<person name="Banham A.H."/>
<person name="Partch C.L."/>
</authorList>
<dbReference type="PubMed" id="25936801"/>
<dbReference type="DOI" id="10.1016/j.molcel.2015.03.031"/>
</citation>
<scope>ASSOCIATION WITH PASD1</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2017" name="Mol. Cell" volume="68" first="198" last="209">
<title>CLOCK acetylates ASS1 to drive circadian rhythm of ureagenesis.</title>
<authorList>
<person name="Lin R."/>
<person name="Mo Y."/>
<person name="Zha H."/>
<person name="Qu Z."/>
<person name="Xie P."/>
<person name="Zhu Z.J."/>
<person name="Xu Y."/>
<person name="Xiong Y."/>
<person name="Guan K.L."/>
</authorList>
<dbReference type="PubMed" id="28985504"/>
<dbReference type="DOI" id="10.1016/j.molcel.2017.09.008"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH ARNTL; ASS1; NDUFA9 AND IMPDH2</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2017" name="Oncotarget" volume="8" first="54913" last="54924">
<title>Cancer/testis antigen PIWIL2 suppresses circadian rhythms by regulating the stability and activity of BMAL1 and CLOCK.</title>
<authorList>
<person name="Lu Y."/>
<person name="Zheng X."/>
<person name="Hu W."/>
<person name="Bian S."/>
<person name="Zhang Z."/>
<person name="Tao D."/>
<person name="Liu Y."/>
<person name="Ma Y."/>
</authorList>
<dbReference type="PubMed" id="28903391"/>
<dbReference type="DOI" id="10.18632/oncotarget.18973"/>
</citation>
<scope>INTERACTION WITH PIWIL2</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2018" name="Proc. Natl. Acad. Sci. U.S.A." volume="115" first="E12305" last="E12312">
<title>Nuclear receptor HNF4A transrepresses CLOCK:BMAL1 and modulates tissue-specific circadian networks.</title>
<authorList>
<person name="Qu M."/>
<person name="Duffy T."/>
<person name="Hirota T."/>
<person name="Kay S.A."/>
</authorList>
<dbReference type="PubMed" id="30530698"/>
<dbReference type="DOI" id="10.1073/pnas.1816411115"/>
</citation>
<scope>INTERACTION WITH HNF4A</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2013" name="Cell Res." volume="23" first="213" last="224">
<title>Intermolecular recognition revealed by the complex structure of human CLOCK-BMAL1 basic helix-loop-helix domains with E-box DNA.</title>
<authorList>
<person name="Wang Z."/>
<person name="Wu Y."/>
<person name="Li L."/>
<person name="Su X.D."/>
</authorList>
<dbReference type="PubMed" id="23229515"/>
<dbReference type="DOI" id="10.1038/cr.2012.170"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 29-89 IN COMPLEX WITH ARNTL AND DNA</scope>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF SER-38; SER-42; PHE-50 AND HIS-84</scope>
</reference>
<comment type="function">
<text evidence="4 9 11 14 16 17 19 20 21 25">Transcriptional activator which forms a core component of the circadian clock. The circadian clock, an internal time-keeping system, regulates various physiological processes through the generation of approximately 24 hour circadian rhythms in gene expression, which are translated into rhythms in metabolism and behavior. It is derived from the Latin roots 'circa' (about) and 'diem' (day) and acts as an important regulator of a wide array of physiological functions including metabolism, sleep, body temperature, blood pressure, endocrine, immune, cardiovascular, and renal function. Consists of two major components: the central clock, residing in the suprachiasmatic nucleus (SCN) of the brain, and the peripheral clocks that are present in nearly every tissue and organ system. Both the central and peripheral clocks can be reset by environmental cues, also known as Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the central clock is light, which is sensed by retina and signals directly to the SCN. The central clock entrains the peripheral clocks through neuronal and hormonal signals, body temperature and feeding-related cues, aligning all clocks with the external light/dark cycle. Circadian rhythms allow an organism to achieve temporal homeostasis with its environment at the molecular level by regulating gene expression to create a peak of protein expression once every 24 hours to control when a particular physiological process is most active with respect to the solar day. Transcription and translation of core clock components (CLOCK, NPAS2, ARNTL/BMAL1, ARNTL2/BMAL2, PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm generation, whereas delays imposed by post-translational modifications (PTMs) are important for determining the period (tau) of the rhythms (tau refers to the period of a rhythm and is the length, in time, of one complete cycle). A diurnal rhythm is synchronized with the day/night cycle, while the ultradian and infradian rhythms have a period shorter and longer than 24 hours, respectively. Disruptions in the circadian rhythms contribute to the pathology of cardiovascular diseases, cancer, metabolic syndromes and aging. A transcription/translation feedback loop (TTFL) forms the core of the molecular circadian clock mechanism. Transcription factors, CLOCK or NPAS2 and ARNTL/BMAL1 or ARNTL2/BMAL2, form the positive limb of the feedback loop, act in the form of a heterodimer and activate the transcription of core clock genes and clock-controlled genes (involved in key metabolic processes), harboring E-box elements (5'-CACGTG-3') within their promoters. The core clock genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form the negative limb of the feedback loop and interact with the CLOCK|NPAS2-ARNTL/BMAL1|ARNTL2/BMAL2 heterodimer inhibiting its activity and thereby negatively regulating their own expression. This heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G, which form a second feedback loop and which activate and repress ARNTL/BMAL1 transcription, respectively. Regulates the circadian expression of ICAM1, VCAM1, CCL2, THPO and MPL and also acts as an enhancer of the transactivation potential of NF-kappaB. Plays an important role in the homeostatic regulation of sleep. The CLOCK-ARNTL/BMAL1 heterodimer regulates the circadian expression of SERPINE1/PAI1, VWF, B3, CCRN4L/NOC, NAMPT, DBP, MYOD1, PPARGC1A, PPARGC1B, SIRT1, GYS2, F7, NGFR, GNRHR, BHLHE40/DEC1, ATF4, MTA1, KLF10 and also genes implicated in glucose and lipid metabolism. Promotes rhythmic chromatin opening, regulating the DNA accessibility of other transcription factors. The CLOCK-ARNTL2/BMAL2 heterodimer activates the transcription of SERPINE1/PAI1 and BHLHE40/DEC1. The preferred binding motif for the CLOCK-ARNTL/BMAL1 heterodimer is 5'-CACGTGA-3', which contains a flanking Ala residue in addition to the canonical 6-nucleotide E-box sequence (PubMed:23229515). CLOCK specifically binds to the half-site 5'-CAC-3', while ARNTL binds to the half-site 5'-GTGA-3' (PubMed:23229515). The CLOCK-ARNTL/BMAL1 heterodimer also recognizes the non-canonical E-box motifs 5'-AACGTGA-3' and 5'-CATGTGA-3' (PubMed:23229515). CLOCK has an intrinsic acetyltransferase activity, which enables circadian chromatin remodeling by acetylating histones and nonhistone proteins, including its own partner ARNTL/BMAL1. Represses glucocorticoid receptor NR3C1/GR-induced transcriptional activity by reducing the association of NR3C1/GR to glucocorticoid response elements (GREs) via the acetylation of multiple lysine residues located in its hinge region (PubMed:21980503). The acetyltransferase activity of CLOCK is as important as its transcription activity in circadian control. Acetylates metabolic enzymes IMPDH2 and NDUFA9 in a circadian manner. Facilitated by BMAL1, rhythmically interacts and acetylates argininosuccinate synthase 1 (ASS1) leading to enzymatic inhibition of ASS1 as well as the circadian oscillation of arginine biosynthesis and subsequent ureagenesis (PubMed:28985504). Drives the circadian rhythm of blood pressure through transcriptional activation of ATP1B1 (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction>
<text>acetyl-CoA + L-lysyl-[protein] = CoA + H(+) + N(6)-acetyl-L-lysyl-[protein]</text>
<dbReference type="Rhea" id="RHEA:45948"/>
<dbReference type="Rhea" id="RHEA-COMP:9752"/>
<dbReference type="Rhea" id="RHEA-COMP:10731"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:29969"/>
<dbReference type="ChEBI" id="CHEBI:57287"/>
<dbReference type="ChEBI" id="CHEBI:57288"/>
<dbReference type="ChEBI" id="CHEBI:61930"/>
<dbReference type="EC" id="2.3.1.48"/>
</reaction>
</comment>
<comment type="activity regulation">
<text evidence="8 19">There is conflicting data about the effect of NAD cofactors on activity. PubMed:11441146 suggests that the redox state of the cell can modulate the transcriptional activity of the CLOCK-ARNTL/BMAL1 heterodimer; NADH and NADPH enhance the DNA-binding activity of the heterodimer. PubMed:23229515 reports that NADH and NADPH have no significant effect on DNA-binding activity of the CLOCK-ARNTL/BMAL1 heterodimer.</text>
</comment>
<comment type="subunit">
<text evidence="4 9 12 13 15 16 18 19 22 23 24 25 26">Component of the circadian clock oscillator which includes the CRY proteins, CLOCK or NPAS2, ARNTL/BMAL1 or ARNTL2/BMAL2, CSNK1D and/or CSNK1E, TIMELESS and the PER proteins (By similarity). Interacts with KMT2A; in a circadian manner (By similarity). Forms a heterodimer with ARNTL/BMAL1 (PubMed:21613214, PubMed:23229515). The CLOCK-ARNTL/BMAL1 heterodimer is required for E-box-dependent transactivation, for CLOCK nuclear translocation and degradation, and for phosphorylation of both CLOCK and ARNTL/BMAL1 (By similarity). Interacts with NR3C1 in a ligand-dependent fashion (PubMed:21980503). Interacts with ESR1 and estrogen stimulates this interaction (PubMed:23160374). Interacts with the complex p35/CDK5 (PubMed:24235147). Interacts with RELA/p65 (By similarity). Interacts with KAT2B, CREBBP, EP300 (PubMed:14645221). Interacts with ID1 and ID3 (By similarity). Interacts with ID2 (PubMed:20861012). Interacts with MTA1 (By similarity). Interacts with OGA (By similarity). Interacts with SIRT1 (By similarity). Interacts with CIPC (By similarity). Interacts with EZH2 (By similarity). Interacts with EIF4E, PIWIL1 and DDX4 (By similarity). Interacts with PER2 and CRY1 and the interaction with PER and CRY proteins requires translocation to the nucleus. Interacts with PER1 and CRY2 (By similarity). Interaction of the CLOCK-ARNTL/BMAL1 heterodimer with PER or CRY inhibits transcription activation (PubMed:21613214). Interaction of the CLOCK-ARNTL/BMAL1 with CRY1 is independent of DNA but with PER2 is off DNA (PubMed:21613214). The CLOCK-ARNTL/BMAL1 heterodimer interacts with GSK3B. Interacts with KDM5A (PubMed:21960634). Interacts with MYBBP1A (By similarity). Interacts with THRAP3 (By similarity). Interacts with MED1; this interaction requires the presence of THRAP3 (By similarity). Interacts with NCOA2 (By similarity). The CLOCK-ARNTL/BMAL1 heterodimer interacts with PASD1 (PubMed:25936801). Interacts with ASS1 and IMPDH2; in a circadian manner (PubMed:28985504). Interacts with NDUFA9 (PubMed:28985504). Interacts with PIWIL2 (via PIWI domain) (PubMed:28903391). Interacts with HNF4A (PubMed:30530698).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1794265">
<id>O15516</id>
</interactant>
<interactant intactId="EBI-1794206">
<id>O00327</id>
<label>ARNTL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1794265">
<id>O15516</id>
</interactant>
<interactant intactId="EBI-11991546">
<id>O00327-8</id>
<label>ARNTL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1794265">
<id>O15516</id>
</interactant>
<interactant intactId="EBI-12268276">
<id>Q8WYA1-3</id>
<label>ARNTL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="9 18 25">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="4">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="25">Cytoplasm</location>
<location evidence="25">Cytosol</location>
</subcellularLocation>
<text evidence="4 14">Shuffling between the cytoplasm and the nucleus is under circadian regulation and is ARNTL/BMAL1-dependent. Phosphorylated form located in the nucleus while the nonphosphorylated form found only in the cytoplasm. Sequestered to the cytoplasm in the presence of ID2 (By similarity). Localizes to sites of DNA damage in a H2AX-independent manner.</text>
</comment>
<comment type="tissue specificity">
<text evidence="7 21">Hair follicles (at protein level). Expressed in all tissues examined including spleen, thymus, prostate, testis, ovary, small intestine, colon, leukocytes, heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. Highest levels in testis and skeletal muscle. Low levels in thymus, lung and liver. Expressed in all brain regions with highest levels in cerebellum. Highly expressed in the suprachiasmatic nucleus (SCN).</text>
</comment>
<comment type="PTM">
<text evidence="4">Ubiquitinated, leading to its proteasomal degradation.</text>
</comment>
<comment type="PTM">
<text evidence="4">O-glycosylated; contains O-GlcNAc. O-glycosylation by OGT prevents protein degradation by inhibiting ubiquitination. It also stabilizes the CLOCK-ARNTL/BMAL1 heterodimer thereby increasing CLOCK-ARNTL/BMAL1-mediated transcriptional activation of PER1/2/3 and CRY1/2.</text>
</comment>
<comment type="PTM">
<text evidence="22">Phosphorylation is dependent on the CLOCK-ARNTL/BMAL1 heterodimer formation. Phosphorylation enhances the transcriptional activity, alters the subcellular localization and decreases the stability of the heterodimer by promoting its degradation. Phosphorylation shows circadian variations in the liver. May be phosphorylated by CSNK1D and CKSN1E.</text>
</comment>
<comment type="PTM">
<text evidence="18">Sumoylation enhances its transcriptional activity and interaction with ESR1, resulting in up-regulation of ESR1 activity. Estrogen stimulates sumoylation. Desumoylation by SENP1 negatively regulates its transcriptional activity. Sumoylation stimulates cell proliferation and increases the proportion of S phase cells in breast cancer cell lines.</text>
</comment>
<comment type="PTM">
<text evidence="4">Undergoes lysosome-mediated degradation in a time-dependent manner in the liver.</text>
</comment>
<comment type="miscellaneous">
<text>CLOCK-ARNTL/BMAL1 double mutations within the PAS domains result in synergistic desensitization to high levels of CRY on repression of CLOCK-ARNTL/BMAl1 transcriptional activity of PER1 and disrupt circadian rhythmicity.</text>
</comment>
<comment type="sequence caution" evidence="27">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA20792" version="2"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<dbReference type="EC" id="2.3.1.48"/>
<dbReference type="EMBL" id="AF011568">
<property type="protein sequence ID" value="AAB83969.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AH008440">
<property type="protein sequence ID" value="AAF13733.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EF015897">
<property type="protein sequence ID" value="ABM64208.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB002332">
<property type="protein sequence ID" value="BAA20792.2"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK291708">
<property type="protein sequence ID" value="BAF84397.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC126157">
<property type="protein sequence ID" value="AAI26158.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC126159">
<property type="protein sequence ID" value="AAI26160.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB005535">
<property type="protein sequence ID" value="BAA21774.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3500.1"/>
<dbReference type="RefSeq" id="NP_001254772.1">
<property type="nucleotide sequence ID" value="NM_001267843.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004889.1">
<property type="nucleotide sequence ID" value="NM_004898.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005265844.1">
<property type="nucleotide sequence ID" value="XM_005265787.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011532711.1">
<property type="nucleotide sequence ID" value="XM_011534409.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011532712.1">
<property type="nucleotide sequence ID" value="XM_011534410.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011532713.1">
<property type="nucleotide sequence ID" value="XM_011534411.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016864343.1">
<property type="nucleotide sequence ID" value="XM_017008854.1"/>
</dbReference>
<dbReference type="PDB" id="4H10">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="B=29-89"/>
</dbReference>
<dbReference type="PDB" id="6QPJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A=105-265"/>
</dbReference>
<dbReference type="PDBsum" id="4H10"/>
<dbReference type="PDBsum" id="6QPJ"/>
<dbReference type="SMR" id="O15516"/>
<dbReference type="BioGRID" id="114944">
<property type="interactions" value="68"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-3229">
<property type="entry name" value="CLOCK-BMAL1 transcription complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-3230">
<property type="entry name" value="CLOCK-BMAL2 transcription complex"/>
</dbReference>
<dbReference type="CORUM" id="O15516"/>
<dbReference type="DIP" id="DIP-46009N"/>
<dbReference type="IntAct" id="O15516">
<property type="interactions" value="16"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000308741"/>
<dbReference type="iPTMnet" id="O15516"/>
<dbReference type="PhosphoSitePlus" id="O15516"/>
<dbReference type="BioMuta" id="CLOCK"/>
<dbReference type="EPD" id="O15516"/>
<dbReference type="jPOST" id="O15516"/>
<dbReference type="MassIVE" id="O15516"/>
<dbReference type="MaxQB" id="O15516"/>
<dbReference type="PaxDb" id="O15516"/>
<dbReference type="PeptideAtlas" id="O15516"/>
<dbReference type="PRIDE" id="O15516"/>
<dbReference type="ProteomicsDB" id="48706"/>
<dbReference type="Antibodypedia" id="909">
<property type="antibodies" value="499 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="9575"/>
<dbReference type="Ensembl" id="ENST00000309964">
<property type="protein sequence ID" value="ENSP00000308741"/>
<property type="gene ID" value="ENSG00000134852"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000381322">
<property type="protein sequence ID" value="ENSP00000370723"/>
<property type="gene ID" value="ENSG00000134852"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000513440">
<property type="protein sequence ID" value="ENSP00000426983"/>
<property type="gene ID" value="ENSG00000134852"/>
</dbReference>
<dbReference type="GeneID" id="9575"/>
<dbReference type="KEGG" id="hsa:9575"/>
<dbReference type="UCSC" id="uc003haz.3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="9575"/>
<dbReference type="DisGeNET" id="9575"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000134852.14"/>
<dbReference type="GeneCards" id="CLOCK"/>
<dbReference type="HGNC" id="HGNC:2082">
<property type="gene designation" value="CLOCK"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000134852">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="601851">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O15516"/>
<dbReference type="OpenTargets" id="ENSG00000134852"/>
<dbReference type="PharmGKB" id="PA26609"/>
<dbReference type="eggNOG" id="KOG3561">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000157580"/>
<dbReference type="HOGENOM" id="CLU_010044_2_2_1"/>
<dbReference type="InParanoid" id="O15516"/>
<dbReference type="KO" id="K02223"/>
<dbReference type="OMA" id="DNLAKCH"/>
<dbReference type="OrthoDB" id="205871at2759"/>
<dbReference type="PhylomeDB" id="O15516"/>
<dbReference type="TreeFam" id="TF324568"/>
<dbReference type="PathwayCommons" id="O15516"/>
<dbReference type="Reactome" id="R-HSA-1368108">
<property type="pathway name" value="BMAL1:CLOCK,NPAS2 activates circadian gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1989781">
<property type="pathway name" value="PPARA activates gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3214847">
<property type="pathway name" value="HATs acetylate histones"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-400253">
<property type="pathway name" value="Circadian Clock"/>
</dbReference>
<dbReference type="SIGNOR" id="O15516"/>
<dbReference type="BioGRID-ORCS" id="9575">
<property type="hits" value="4 hits in 890 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="CLOCK">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="CLOCK"/>
<dbReference type="GenomeRNAi" id="9575"/>
<dbReference type="Pharos" id="O15516">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:O15516"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 4"/>
</dbReference>
<dbReference type="RNAct" id="O15516">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000134852">
<property type="expression patterns" value="Expressed in secondary oocyte and 248 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O15516">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O15516">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0033391">
<property type="term" value="C:chromatoid body"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005694">
<property type="term" value="C:chromosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005667">
<property type="term" value="C:transcription regulator complex"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0031490">
<property type="term" value="F:chromatin DNA binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070888">
<property type="term" value="F:E-box binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004402">
<property type="term" value="F:histone acetyltransferase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046983">
<property type="term" value="F:protein dimerization activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043565">
<property type="term" value="F:sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990837">
<property type="term" value="F:sequence-specific double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071479">
<property type="term" value="P:cellular response to ionizing radiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032922">
<property type="term" value="P:circadian regulation of gene expression"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007623">
<property type="term" value="P:circadian rhythm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000077">
<property type="term" value="P:DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000323">
<property type="term" value="P:negative regulation of glucocorticoid receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009648">
<property type="term" value="P:photoperiodism"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043161">
<property type="term" value="P:proteasome-mediated ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006473">
<property type="term" value="P:protein acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042752">
<property type="term" value="P:regulation of circadian rhythm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042634">
<property type="term" value="P:regulation of hair cycle"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050796">
<property type="term" value="P:regulation of insulin secretion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000074">
<property type="term" value="P:regulation of type B pancreatic cell development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051775">
<property type="term" value="P:response to redox state"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007283">
<property type="term" value="P:spermatogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00083">
<property type="entry name" value="HLH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd00130">
<property type="entry name" value="PAS"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="4.10.280.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00430"/>
<dbReference type="InterPro" id="IPR011598">
<property type="entry name" value="bHLH_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036638">
<property type="entry name" value="HLH_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001067">
<property type="entry name" value="Nuc_translocat"/>
</dbReference>
<dbReference type="InterPro" id="IPR001610">
<property type="entry name" value="PAC"/>
</dbReference>
<dbReference type="InterPro" id="IPR000014">
<property type="entry name" value="PAS"/>
</dbReference>
<dbReference type="InterPro" id="IPR035965">
<property type="entry name" value="PAS-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013767">
<property type="entry name" value="PAS_fold"/>
</dbReference>
<dbReference type="Pfam" id="PF00010">
<property type="entry name" value="HLH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00989">
<property type="entry name" value="PAS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00785">
<property type="entry name" value="NCTRNSLOCATR"/>
</dbReference>
<dbReference type="SMART" id="SM00353">
<property type="entry name" value="HLH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00086">
<property type="entry name" value="PAC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00091">
<property type="entry name" value="PAS"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47459">
<property type="entry name" value="SSF47459"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55785">
<property type="entry name" value="SSF55785"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50888">
<property type="entry name" value="BHLH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50112">
<property type="entry name" value="PAS"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0012">Acyltransferase</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Circadian locomoter output cycles protein kaput" id="PRO_0000127163">
<location>
<begin position="1"/>
<end position="846"/>
</location>
</feature>
<feature type="domain" description="bHLH" evidence="6">
<location>
<begin position="34"/>
<end position="84"/>
</location>
</feature>
<feature type="domain" description="PAS 1" evidence="5">
<location>
<begin position="107"/>
<end position="177"/>
</location>
</feature>
<feature type="domain" description="PAS 2" evidence="5">
<location>
<begin position="262"/>
<end position="332"/>
</location>
</feature>
<feature type="domain" description="PAC">
<location>
<begin position="336"/>
<end position="379"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with NR3C1" evidence="4">
<location>
<begin position="371"/>
<end position="845"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SIRT1" evidence="4">
<location>
<begin position="450"/>
<end position="570"/>
</location>
</feature>
<feature type="region of interest" description="Implicated in the circadian rhythmicity" evidence="3">
<location>
<begin position="514"/>
<end position="564"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="4">
<location>
<begin position="32"/>
<end position="47"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gln-rich">
<location>
<begin position="744"/>
<end position="760"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="819"/>
<end position="828"/>
</location>
</feature>
<feature type="site" description="Interaction with E-box DNA" evidence="19">
<location>
<position position="39"/>
</location>
</feature>
<feature type="site" description="Interaction with E-box DNA" evidence="19">
<location>
<position position="43"/>
</location>
</feature>
<feature type="site" description="Interaction with E-box DNA" evidence="19">
<location>
<position position="47"/>
</location>
</feature>
<feature type="site" description="Important for interaction with ARNTL/BMAL1" evidence="19">
<location>
<position position="84"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="38"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="42"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="408"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by GSK3-beta" evidence="4">
<location>
<position position="427"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="431"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK5" evidence="22">
<location>
<position position="451"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK5" evidence="22">
<location>
<position position="461"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)" evidence="4">
<location>
<position position="67"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)" evidence="4">
<location>
<position position="842"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34897046." id="VAR_040061">
<original>S</original>
<variation>C</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1056478." id="VAR_040062">
<original>E</original>
<variation>K</variation>
<location>
<position position="380"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6855837." id="VAR_029076">
<original>L</original>
<variation>I</variation>
<location>
<position position="395"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3762836." id="VAR_029077">
<original>H</original>
<variation>R</variation>
<location>
<position position="542"/>
</location>
</feature>
<feature type="mutagenesis site" description="Phosphomimetic mutant with no effect on DNA binding or CLOCK-ARNTL/BMAL1 transcriptional activity." evidence="19">
<original>S</original>
<variation>E</variation>
<location>
<position position="38"/>
</location>
</feature>
<feature type="mutagenesis site" description="Phosphomimetic mutant with no effect on DNA binding or CLOCK-ARNTL/BMAL1 transcriptional activity." evidence="19">
<original>S</original>
<variation>E</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on ARNTL/BMAL1 binding." evidence="19">
<original>F</original>
<variation>M</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired ARNTL/BMAL1 binding." evidence="19">
<original>H</original>
<variation>L</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="mutagenesis site" description="3-fold increase in PER1 reporter activity by CLOCK-ARNTL/BMAL1. Some reduction of CRY1 inhibition of CLOCK-ARNTL/BMAL1 transcriptional activity; when associated with K-367 and L-601." evidence="10">
<original>E</original>
<variation>K</variation>
<location>
<position position="116"/>
</location>
</feature>
<feature type="mutagenesis site" description="3-fold increase in PER1 reporter activity by CLOCK-ARNTL/BMAL1. Some reduction of CRY1 inhibition of CLOCK-ARNTL/BMAL1 transcriptional activity; when associated with L-840." evidence="10">
<original>G</original>
<variation>E</variation>
<location>
<position position="332"/>
</location>
</feature>
<feature type="mutagenesis site" description="3-fold increase in PER1 reporter activity by CLOCK-ARNTL/BMAL1. Some reduction of CRY1 inhibition of CLOCK-ARNTL/BMAL1 transcriptional activity." evidence="10">
<original>H</original>
<variation>Y</variation>
<location>
<position position="360"/>
</location>
</feature>
<feature type="mutagenesis site" description="3-fold increase in PER1 reporter activity by CLOCK-ARNTL/BMAL1. Some reduction of CRY1 inhibition of CLOCK-ARNTL/BMAL1 transcriptional activity; when associated with E-116 and L-601." evidence="10">
<original>E</original>
<variation>K</variation>
<location>
<position position="367"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significant loss in phosphorylation." evidence="22">
<original>T</original>
<variation>F</variation>
<location>
<position position="451"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significant loss in phosphorylation." evidence="22">
<original>T</original>
<variation>F</variation>
<location>
<position position="461"/>
</location>
</feature>
<feature type="mutagenesis site" description="3-fold increase in PER1 reporter activity by CLOCK-ARNTL/BMAL1. Some reduction of CRY1 inhibition of CLOCK-ARNTL/BMAL1 transcriptional activity; when associated with K-116 and K-367." evidence="10">
<original>V</original>
<variation>L</variation>
<location>
<position position="601"/>
</location>
</feature>
<feature type="mutagenesis site" description="3-fold increase in PER1 reporter activity by CLOCK-ARNTL/BMAL1. Some reduction of CRY1 inhibition of CLOCK-ARNTL/BMAL1 transcriptional activity; when associated with E-332." evidence="10">
<original>P</original>
<variation>L</variation>
<location>
<position position="840"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAF13733." ref="1" evidence="27">
<original>S</original>
<variation>P</variation>
<location>
<position position="440"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="33"/>
<end position="58"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="61"/>
<end position="63"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="70"/>
<end position="89"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="107"/>
<end position="118"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="120"/>
<end position="126"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="130"/>
<end position="134"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="138"/>
<end position="142"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="146"/>
<end position="149"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="154"/>
<end position="156"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="160"/>
<end position="162"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="163"/>
<end position="174"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="182"/>
<end position="184"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="191"/>
<end position="198"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="210"/>
<end position="221"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="249"/>
<end position="257"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4H10"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6QPJ"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O08785"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00140"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00981"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10198158"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11441146"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14645221"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16474406"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18587630"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20861012"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21613214"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21659603"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21960634"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21980503"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22284746"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23160374"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23229515"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23785138"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24005054"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24235147"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25936801"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28903391"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28985504"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30530698"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000305"/>
<sequence length="846" mass="95304" checksum="C292B451A33E4CBF" modified="1998-01-01" version="1">MLFTVSCSKMSSIVDRDDSSIFDGLVEEDDKDKAKRVSRNKSEKKRRDQFNVLIKELGSMLPGNARKMDKSTVLQKSIDFLRKHKEITAQSDASEIRQDWKPTFLSNEEFTQLMLEALDGFFLAIMTDGSIIYVSESVTSLLEHLPSDLVDQSIFNFIPEGEHSEVYKILSTHLLESDSLTPEYLKSKNQLEFCCHMLRGTIDPKEPSTYEYVKFIGNFKSLNSVSSSAHNGFEGTIQRTHRPSYEDRVCFVATVRLATPQFIKEMCTVEEPNEEFTSRHSLEWKFLFLDHRAPPIIGYLPFEVLGTSGYDYYHVDDLENLAKCHEHLMQYGKGKSCYYRFLTKGQQWIWLQTHYYITYHQWNSRPEFIVCTHTVVSYAEVRAERRRELGIEESLPETAADKSQDSGSDNRINTVSLKEALERFDHSPTPSASSRSSRKSSHTAVSDPSSTPTKIPTDTSTPPRQHLPAHEKMVQRRSSFSSQSINSQSVGSSLTQPVMSQATNLPIPQGMSQFQFSAQLGAMQHLKDQLEQRTRMIEANIHRQQEELRKIQEQLQMVHGQGLQMFLQQSNPGLNFGSVQLSSGNSSNIQQLAPINMQGQVVPTNQIQSGMNTGHIGTTQHMIQQQTLQSTSTQSQQNVLSGHSQQTSLPSQTQSTLTAPLYNTMVISQPAAGSMVQIPSSMPQNSTQSAAVTTFTQDRQIRFSQGQQLVTKLVTAPVACGAVMVPSTMLMGQVVTAYPTFATQQQQSQTLSVTQQQQQQSSQEQQLTSVQQPSQAQLTQPPQQFLQTSRLLHGNPSTQLILSAAFPLQQSTFPQSHHQQHQSQQQQQLSRHRTDSLPDPSKVQPQ</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

